Vanessa Lisbeth Rubin

This inventor holds 1 USPTO granted patent. Top assignee: H. Lundbeck A/s. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vanessa Lisbeth Rubin. Retrieved from https://idiyas.com/inventor/vanessa-lisbeth-rubin-kywbo90j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vanessa Lisbeth Rubin: Innovator in Antibody Development

Introduction

Vanessa Lisbeth Rubin is a notable inventor recognized for her contributions to the field of biotechnology. She has made significant strides in the development of humanized antibodies, which are crucial for various therapeutic applications. Her work is particularly focused on addressing medical challenges through innovative solutions.

Latest Patents

Vanessa holds a patent titled "Nucleic Acids Encoding Humanized Anti-Pacap Antibodies." This patent represents her commitment to advancing medical science and improving treatment options for patients. With 1 patent to her name, she exemplifies the spirit of innovation in her field.

Career Highlights

Vanessa is currently employed at H. Lundbeck A/S, a company renowned for its dedication to improving the lives of people with brain diseases. Her role at the company allows her to leverage her expertise in biotechnology and contribute to groundbreaking research and development.

Collaborations

Throughout her career, Vanessa has collaborated with talented individuals such as Maria-Cristina Loomis and Leon F. Garcia-Martinez. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their research.

Conclusion

Vanessa Lisbeth Rubin is a pioneering inventor whose work in antibody development is making a significant impact in the field of biotechnology. Her dedication to innovation and collaboration continues to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…